Sorry, Your Requested Page Was Not Found.
Greetings! We apologize for the inconvenience, but the page, Press Release Curium Enrolls First Prostate Cancer Patients In Its Phase 3 Solar Trials is no longer available. Please use our search box below to find related content and browse the list of related news stories. Depending on the topic, news articles are deleted 3 - 18 months after the created date. We prefer to keep content fresh and current and not keep old news. Thanks for visiting today.Search RobinsPost News & Noticias
Curium Enrolls First Prostate Cancer Patients in its Phase 3 SOLAR Trials - Yahoo Finance
ST. LOUIS, April 23, 2024 (GLOBE NEWSWIRE) -- Curium, a world leader in nuclear medicine, announced today that it has successfully enrolled and scanned patients in its SOLAR clinical trials: The ... Read More
Curium Completes Enrollment Early of Phase 3 SOLAR-RECUR Prostate Cancer Trial - Yahoo Finance
ST. LOUIS, Mo., Nov. 19, 2024 (GLOBE NEWSWIRE) -- Curium, a world leader in nuclear medicine, announced that it has completed enrollment of its Phase 3 SOLAR-RECUR clinical trial. The trial is a ... Read More
Curium Enrolls First Prostate Cancer Patients in its Phase 3 SOLAR Trials - FinanzNachrichten.de
ST. LOUIS, April 23, 2024 (GLOBE NEWSWIRE) -- Curium, a world leader in nuclear medicine, announced today that it has successfully enrolled and scanned patients in its SOLAR clinical trials: The first ... Read More
Curium Completes Enrollment Early of Phase 3 SOLAR-RECUR Prostate Cancer Trial - Financial Post
LOUIS, Mo., Nov. 19, 2024 (GLOBE NEWSWIRE) — Curium, a world leader in nuclear medicine, announced that it has completed enrollment of its Phase 3 SOLAR-RECUR clinical trial. The trial is a ... Read More
Curium Completes Enrollment Early of Phase 3 SOLAR-RECUR Prostate Cancer Trial - Markets Insider
ST. LOUIS, Mo., Nov. 19, 2024 (GLOBE NEWSWIRE) -- Curium, a world leader in nuclear medicine, announced that it has completed enrollment of its Phase 3 SOLAR-RECUR clinical trial. The trial is a ... Read More
Curium Completes Enrollment Early of Phase 3 SOLAR-RECUR Prostate Cancer Trial - The Manila Times
ST. LOUIS, Mo., Nov. 19, 2024 (GLOBE NEWSWIRE) -- Curium, a world leader in nuclear medicine, announced that it has completed enrollment of its Phase 3 SOLAR-RECUR clinical trial. The trial is a ... Read More
Blow Us A Whistle
Comments (Whistles) Designed By Disqus